For five years straight, patients responding to the State of Patient Access survey have ranked “seeing a doctor quickly” as a top priority. Unfortunately, 94% of patients are still waiting more than two weeks for an appointment. Too many find themselves stuck in scheduling dead-ends, with unanswered calls, endless hold times and limited options when…
Personify Health Chief Medical Officer Jeff Jacques offers a window into companies’ strategies for including GLP-1 drugs in their health benefits. The post MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs appeared first on MedCity News.
This resource provides an overview of where the U.S. operates bilateral global health programs by country and region.
A paper by Qato et al. (2024) quantifies the degree of of pharmacy benefit manager (PBM) market concentration. Across all payer types, the PBM market was highly concentrated, with an HHI [Herfindahl Hirschman Index (HHI)] of 1972…the HHI was lowest in commercial insurance (1940), with 90 PBM participants, and highest in Medicare Part D (2399),…
SIKESTON, Mo. — For residents of Sikeston, as for Black Americans around the country, speaking openly about experiences with racial violence can be taboo and, in some cases, forbidden. As a child, Larry McClellon’s mother told him not to ask too many questions about the 1942 lynching of Cleo Wright in their hometown of Sikeston….
The growth rate of Medicare Advantage patients activity with physicians and outpatient providers early this year was nearly double what the company had expected.
Charity Tarn, an investor with Arboretum Ventures, will be one of the investor judges for the Pitch Perfect contest at INVEST in Chicago May 20-21. Register today! The post Arboretum Ventures Investor Says Startups Are Adapting to Tough Healthcare Fundraising Environment appeared first on MedCity News.
Missed payments, delayed reimbursements and rising debt are often symptoms of a struggling financial clearance process. According to Experian Health’s State of Patient Access survey, more than six in ten patients say they’d feel more confident about covering their portion of healthcare costs if offered a payment plan. Still, many remain unaware of financial assistance…
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley. The post “Precision Med Has Evolved as Badly As I Expected” And OtherTakeaways From Former FDA Commissioner At PMWC appeared first…
Jazz Pharmaceuticals’ acquisition of Chimerix brings a drug that could become the first approved therapy for a rare and aggressive form of brain cancer affecting children and young adults. An FDA decision for the molecule, dordaviprone, is expected in August. The post First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune…